Per-Olof Bertil Gunnesson
Président chez Kampavata AB
Profil
Per-Olof Bertil Gunnesson is currently the Chairman of Helicure AB, Chairman of Kampavata AB, Director of Bostadsrättsföreningen Kungsängen 6, External Vice President of InDex Diagnostics AB, and Chief Financial Officer of InDex Pharmaceuticals AB.
He previously held positions as Chairman of Helicure AB, Director of Astra Pharmaceuticals AB, Director of Umecrine AB, Chief Financial Officer & Independent Director of Mendus AB, Director of Imeco AB, Director of AstraZeneca Medical AB, Director of AstraZeneca Sverige AB, Principal of Astra AB, and External Vice President of InDex Pharmaceuticals Holding AB.
Gunnesson received an undergraduate degree from Handelshögskolan i Göteborg.
Postes actifs de Per-Olof Bertil Gunnesson
| Sociétés | Poste | Début |
|---|---|---|
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Directeur/Membre du Conseil | 07/01/2008 |
| Kampavata AB | Président | 06/04/2006 |
| Bostadsrättsföreningen Kungsängen 6 | Directeur/Membre du Conseil | 03/07/2008 |
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Président | - |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Directeur Financier/CFO | 01/01/2003 |
Anciens postes connus de Per-Olof Bertil Gunnesson
| Sociétés | Poste | Fin |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Directeur Financier/CFO | 01/05/2017 |
| MENDUS AB | Directeur Financier/CFO | 01/10/2015 |
Umecrine AB
 Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Directeur/Membre du Conseil | 01/01/2015 |
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Président | 01/01/2013 |
| ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Per-Olof Bertil Gunnesson
| Handelshögskolan i Göteborg | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| MENDUS AB | Health Technology |
| Entreprise privées | 11 |
|---|---|
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
| Astra Pharmaceuticals AB | |
Umecrine AB
Umecrine AB BiotechnologyHealth Technology Umecrine AB provides pharmaceuticals against mental and physical symptoms. It develops antagonists to reduce symptoms and conditions caused by endogenous sex and stress hormones on the brain. The company was founded by Carl Torbjörn Bäckström in 2000 and is headquartered in Umea, Sweden. | Health Technology |
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
| Kampavata AB | |
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Health Technology |
| Imeco AB | |
| AstraZeneca Medical AB | |
| AstraZeneca Sverige AB | |
| Bostadsrättsföreningen Kungsängen 6 | |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Health Technology |